Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Feb 29, 2024 | (FY)Feb 28, 2023 | (FY)Feb 28, 2022 | (FY)Feb 28, 2021 | (FY)Feb 29, 2020 | (FY)Feb 28, 2019 | (FY)Feb 28, 2018 | (FY)Feb 28, 2017 | (FY)Feb 29, 2016 | (FY)Feb 28, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -220.53%-1.34B | 25.15%1.11B | 359.17%889.71M | -80.86%193.76M | 181.34%1.01B | -27.25%-1.24B | -86.44%-978.22M | -89.47%-524.68M | 60.18%-276.91M | -285.82%-695.33M |
Net profit before non-cash adjustment | -81.34%253.14M | -18.80%1.36B | 159.93%1.67B | -288.34%-2.79B | 141.37%1.48B | -54.26%613.42M | 54.88%1.34B | 184.63%865.89M | -5,780.12%-1.02B | 98.63%-17.4M |
Total adjustment of non-cash items | -311.28%-134.2M | 139.11%63.52M | -138.08%-162.43M | 206.88%426.56M | -2,959.45%-399.09M | -86.90%13.96M | 285.43%106.52M | -95.04%27.64M | 358.46%557.47M | -78.71%121.6M |
-Depreciation and amortization | 17.95%7.51M | 111.54%6.36M | -11.87%3.01M | 32.24%3.41M | -25.36%2.58M | 75.71%3.46M | -42.07%1.97M | -45.02%3.4M | 164.40%6.18M | -96.21%2.34M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8,664.76%341.48M | -100.21%-3.99M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 14,716.69%220.71M | -101.81%-1.51M |
-Share of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.03%425K |
-Disposal profit | ---- | ---- | ---78.59M | ---- | ---- | ---- | ---- | ---80.34M | ---- | 119.76%98.93M |
-Other non-cash items | -347.93%-141.7M | 165.82%57.15M | -120.52%-86.84M | 205.35%423.15M | -3,925.84%-401.68M | -89.96%10.5M | -0.03%104.56M | 1,059.41%104.59M | -142.92%-10.9M | 124.71%25.4M |
Changes in working capital | -375.87%-1.46B | 50.41%-307.02M | -124.22%-619.06M | 3,801.75%2.56B | 96.31%-69.05M | 22.82%-1.87B | -71.05%-2.43B | -851.32%-1.42B | 123.61%188.76M | -253.60%-799.53M |
-Change in inventory | -536.83%-2.15B | -132.50%-338.15M | -105.26%-145.44M | 240.21%2.76B | -9.56%-1.97B | 12.58%-1.8B | -123.47%-2.06B | -400.72%-920.73M | 143.81%306.17M | -744.36%-698.89M |
-Change in prepaid assets | ---- | ---- | ---- | ---- | 432.87%1.28B | 177.95%239.5M | 47.59%-307.23M | -1,634.81%-586.21M | 67.62%-33.79M | -132.64%-104.37M |
-Change in payables | 1,724.08%29.24M | 40.00%1.6M | 272.44%1.15M | -567.61%-664K | 100.04%142K | -201.70%-376.06M | 12,250.80%369.78M | 103.58%2.99M | -2,346.67%-83.62M | -96.97%3.72M |
-Provision for loans, leases and other losses | -193.52%-17.81M | 116.04%19.05M | -7,995.23%-118.76M | -102.16%-1.47M | 12.39%67.88M | 214.85%60.4M | 29.46%19.18M | --14.82M | ---- | ---- |
-Changes in other current assets | 6,397.01%681.02M | 102.94%10.48M | -73.66%-356M | -136.78%-205M | 20,540.74%557.3M | 100.60%2.7M | -734.50%-450M | --70.92M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 31.56%-6.91M | -113.03%-10.09M | 11.28%-4.74M | -12.38%-5.34M | 84.79%-4.75M | -91.75%-31.23M | -169.67%-16.29M | -185.31%-6.04M | 59.44%-2.12M | 91.30%-5.22M |
Interest received (cash flow from operating activities) | 141.92%42.71M | -34.01%17.66M | 631.76%26.75M | -81.16%3.66M | 3,734.58%19.4M | 163.54%506K | -90.05%192K | -68.08%1.93M | 109.93%6.05M | -65.71%2.88M |
Tax refund paid | -7,216.37%-85.82M | -234.19%-1.17M | 99.43%-351K | 73.16%-61.11M | -15.83%-227.66M | -217.35%-196.55M | 198.36%167.49M | -717.78%-170.29M | -62.66%27.56M | 316.20%73.82M |
Other operating cash inflow (outflow) | 0 | -1K | 0 | 0 | 0.00%-1K | -200.00%-1K | 1K | 0 | 0.00%1K | 200.00%1K |
Operating cash flow | -224.31%-1.39B | 22.87%1.12B | 595.86%911.38M | -83.62%130.97M | 154.31%799.47M | -78.03%-1.47B | -18.28%-826.83M | -184.85%-699.07M | 60.66%-245.42M | -134.53%-623.85M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3,052.90%200M | -101.91%-6.77M | -53.80%353.99M |
Net investment product transactions | --0 | ---20M | --0 | ---20M | ---- | ---- | ---80M | ---- | ---- | 100.78%456K |
Advance cash and loans provided to other parties | ---- | -204.54%-1.56B | ---513.07M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | --2.13B | ---- | -55.19%120.6M | 142.38%269.13M | -238.74%-635.1M | 179.20%457.76M | ---578.02M | ---- | -175.00%-88M | -144.08%-32M |
Net changes in other investments | 98.03%-559K | -818.61%-28.38M | 322.48%3.95M | 76.89%-1.78M | -109.59%-7.68M | -27.28%80.12M | 169.08%110.17M | -1,566.68%-159.49M | -75.28%10.87M | 619.74%44M |
Investing cash flow | 232.34%2.13B | -314.62%-1.61B | -257.07%-388.52M | 138.48%247.36M | -219.50%-642.78M | 198.18%537.88M | -1,452.27%-547.85M | 148.29%40.51M | -122.90%-83.9M | -52.44%366.44M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 159.54%476.07M | 820.88%183.43M | -89.58%19.92M | 199.90%191.2M | 83.05%-191.4M | -374.15%-1.13B | -54.97%412M | 632.00%915M | -33.97%125M | 132.44%189.3M |
Net common stock issuance | ---- | ---- | ---84.52M | ---- | ---- | 731.44%1.91B | -75.39%229.18M | --931.14M | ---- | --446.8M |
Cash dividends paid | -0.48%-142.24M | ---141.56M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | 840,100.00%8.4M | ---1K | ---- | ---- | ---- | ---- | ---- | --9.9M | ---- | ---- |
Financing cash flow | 717.44%342.23M | 164.81%41.87M | -133.79%-64.6M | 199.90%191.2M | -124.66%-191.4M | 21.03%776M | -65.45%641.18M | 1,384.83%1.86B | -80.35%125M | 207.64%636.1M |
Net cash flow | ||||||||||
Beginning cash position | -25.20%1.33B | 34.61%1.78B | 75.50%1.32B | -4.40%754.36M | -16.70%789.07M | -43.64%947.24M | 247.79%1.68B | -29.72%483.26M | 122.60%687.58M | -21.87%308.88M |
Current changes in cash | 340.86%1.08B | -198.02%-449.19M | -19.54%458.26M | 1,740.82%569.53M | 78.05%-34.71M | 78.44%-158.17M | -161.25%-733.5M | 686.09%1.2B | -153.95%-204.32M | 538.03%378.69M |
Cash adjustments other than cash changes | ---- | ---- | ---- | --1K | ---- | ---- | -300.00%-2K | 200.00%1K | ---1K | ---- |
End cash Position | 81.17%2.41B | -25.20%1.33B | 34.61%1.78B | 75.50%1.32B | -4.40%754.36M | -16.70%789.07M | -43.64%947.24M | 247.79%1.68B | -29.72%483.26M | 122.60%687.58M |
Free cash flow | -224.31%-1.39B | 22.87%1.12B | 595.86%911.38M | -83.62%130.97M | 154.31%799.47M | -78.03%-1.47B | -18.28%-826.83M | -177.20%-699.07M | 59.57%-252.19M | -32.89%-623.85M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |